In United States, meniere Disease is managed by ents. Meniere's disease is a chronic disorder of the inner ear in which excess endolymph fluid (endolymphatic hydrops) distorts the membranous labyrinth, producing repeated attacks of spinning vertigo, fluctuating hearing loss, tinnitus, and a pressure sensation in one ear. It affects roughly 0.05-0.2% of adults in the United States — about 615,000 people according to NIDCD — and typically begins between ages 40 and 60, with a slight female predominance.
Meniere's disease (ICD-10: H81.0) is an idiopathic inner-ear disorder defined by recurrent episodic vertigo together with cochlear symptoms — sensorineural hearing loss, tinnitus, and aural fullness — attributable to a single (or eventually both) ear. The pathological substrate, identified by Hallpike and Cairns in 1938, is endolymphatic hydrops: a distension of the endolymph-filled scala media inside the cochlea and the membranous portions of the vestibular labyrinth. Why hydrops develops is unsettled; current theories include malabsorption at the endolymphatic sac, immune-mediated injury, vascular dysregulation, and genetic predisposition. The 2015 Bárány Society consensus criteria define definite Meniere's disease as at least two spontaneous vertigo episodes lasting 20 minutes to 12 hours, audiometrically documented low-to-mid frequency sensorineural hearing loss in the affected ear on at least one occasion, and fluctuating aural symptoms (hearing, tinnitus, or fullness) in that same ear, with no better explanation.
The key symptoms of Meniere Disease are: Spontaneous attacks of true rotational vertigo lasting 20 minutes to 12 hours, with a sense that the room or the patient is spinning rather than light-headed swaying., Fluctuating sensorineural hearing loss in the affected ear, predominantly at low frequencies early in the disease, that can briefly improve between attacks before becoming permanent over years., Tinnitus in the affected ear, typically a low-pitched roaring or 'seashell' sound that intensifies before or during a vertigo attack., A sensation of fullness, pressure, or blockage in the affected ear, often the earliest warning that an attack is approaching., Severe nausea and vomiting during the vertigo attack, frequently requiring the patient to lie still in a dark room for hours., Disequilibrium and unsteadiness for 24-72 hours after an attack resolves, with normal balance returning gradually., Horizontal-rotary nystagmus during an attack, visible to a clinician using Frenzel goggles or video-oculography..
Meniere's disease is diagnosed clinically using the 2015 Bárány Society consensus criteria — there is no single confirmatory test. The first step is a detailed history that captures the duration of vertigo attacks (20 minutes to 12 hours is the diagnostic window), the pattern of auditory symptoms in the affected ear, and the presence of fullness or tinnitus that fluctuates with attacks. Pure-tone audiometry is the single most important objective test: a low-to-mid frequency sensorineural hearing loss (averaging the 0.5, 1, and 2 kHz thresholds) of at least 30 dB compared with the contralateral ear documented on at least one occasion meets the audiometric criterion. Word recognition and tympanometry round out the audiogram. Vestibular testing — videonystagmography (VNG), caloric testing, cervical and ocular VEMP, and video head impulse testing (vHIT) — quantifies unilateral vestibular weakness and helps localize the disease. Electrocochleography (ECochG) shows an elevated summating-potential to action-potential ratio above 0.35-0.4 in many Meniere's patients, supporting hydrops but with limited sensitivity. MRI of the internal auditory canal with gadolinium is mandatory to exclude vestibular schwannoma, multiple sclerosis, and other retrocochlear pathology; delayed gadolinium-enhanced MRI can now directly visualize endolymphatic hydrops at specialist centers, though it is not yet routine. Laboratory testing — treponemal serology, antinuclear antibodies, thyroid function, and selected autoimmune panels — is used to rule out secondary causes, especially in bilateral or atypical presentations. The 2020 AAO-HNS Clinical Practice Guideline (Basura et al.) emphasizes that diagnosis is clinical and explicitly recommends against routine ordering of ECochG or other unproven tests outside specialist evaluation.
Meniere's disease is a fluctuating, lifelong condition rather than a steadily progressive one. Vertigo attacks typically cluster in flares interspersed with quiescent intervals, and the natural history shows that vertigo frequency tends to decline after 5-10 years even without intervention as vestibular function in the affected ear gradually 'burns out'. Hearing, however, deteriorates progressively — the average affected ear ends with moderate-to-severe sensorineural hearing loss after 10-20 years, particularly at low and high frequencies. Bilateral involvement reaches 25-30% at 5 years and 35-50% at 10-20 years. With stepwise treatment, more than 80% of patients achieve substantial vertigo control. Tumarkin drop attacks occur in 5-10% and demand prompt escalation because of fall and fracture risk. Mortality is not increased, but quality-of-life scores fall to levels comparable with severe migraine and inflammatory bowel disease, and disability-related work absence is common during high-attack periods. Early diagnosis, hearing aid fitting, and active management of comorbid anxiety and migraine improve long-term outcomes.
An otolaryngologist or neuro-otologist should evaluate any adult with episodic vertigo plus auditory symptoms that fit the Bárány criteria. Specialist input is essential because diagnosis is clinical, MRI is required to exclude retrocochlear pathology, intratympanic therapy and surgery must be performed by trained ear surgeons, and audiologic monitoring guides each step of the treatment ladder. Most cases stabilize with specialist-supervised medical therapy; surgical referral is needed in 10-20%.
Find specialists →A single attack peaks within 1-2 hours and resolves over 20 minutes to 12 hours, with most patients drained and unsteady for 24-72 hours afterward. Lifestyle and diuretic responses are typically seen by 2-3 months; betahistine is reassessed at 3 months. Intratympanic dexamethasone vertigo control develops over 1-4 weeks; intratympanic gentamicin within 4-8 weeks. After surgical labyrinthectomy or vestibular nerve section, central compensation guided by vestibular rehabilitation takes 6-12 weeks for most patients. Hearing decline is slow but cumulative over years; periodic audiometry is the most reliable progress marker.
Regular aerobic exercise is safe and recommended between attacks. During an acute attack, rest quietly with the head still until rotational vertigo subsides, then resume gentle activity. Vestibular rehabilitation exercises, prescribed by a trained physiotherapist, are the single most useful exercise intervention and accelerate compensation after attacks or intratympanic gentamicin. Avoid contact sports, scuba diving, and high-altitude exposure during periods of active disease because pressure changes can precipitate attacks.
Look for board certification in otolaryngology with subspecialty training or interest in neuro-otology, in-office availability of intratympanic injections, a dedicated audiology service for serial audiograms and hearing rehabilitation, and access to vestibular testing (VNG, vHIT, VEMP). Patients with refractory disease benefit from referral to a centre that performs endolymphatic sac surgery, vestibular nerve section, and cochlear implantation. Continuity matters — Meniere's is a multi-year relationship and consistent audiometric tracking is the backbone of management.
Medically reviewed by AIHealz Medical Editorial Board · May 12, 2026
Ranked by patient outcomes and specialized experience.
Specialists who treat Meniere Disease. Get expert guidance and personalized care.